Autologous bone marrow transplantation in acute lymphoblastic leukaemia (Q40558267)

21 September 2017

1 reference

title

Autologous bone marrow transplantation in acute lymphoblastic leukaemia (English)

1 reference

21 September 2017

1 reference

Carella AM

1

1 reference

PubMed ID

7803909

21 September 2017

Marmont AM

series ordinal

2

1 reference

21 September 2017

1 June 1994

1 reference

Best Practice and Research: Clinical Haematology

21 September 2017

1 reference

21 September 2017

7

1 reference

21 September 2017

2

1 reference

21 September 2017

403-419

1 reference

Minimal residual disease in acute lymphoblastic leukemia detected by immune selection and gene rearrangement analysis

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Intensified induction and consolidation with or without maintenance chemotherapy for acute myeloid leukemia (AML): two multicenter studies of the German AML Cooperative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Mobilization of cytogenetically 'normal' blood progenitors cells by intensive conventional chemotherapy for chronic myeloid and acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Ex-vivo treatment of donor bone marrow with anti-T-cell immunotoxins for prevention of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

A cause-specific hazard rate analysis of prognostic factors among 199 adults with acute lymphoblastic leukemia: the Memorial Hospital experience since 1969.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Granulocyte-macrophage colony-stimulating factor to harvest circulating haemopoietic stem cells for autotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Ex vivo and conditioning chemotherapy for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Chemotherapy compared with bone marrow transplantation for adults with acute lymphoblastic leukemia in first remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Selective killing of leukaemia cells by antibody-toxin conjugates: implications for autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

The use of monoclonal antibodies for purging autologous bone marrow in the lymphoid malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Autologous Bone-Marrow Transplantation in Acute Lymphoblastic Leukaemia: 1980-89

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Correlation of karyotype and immunophenotype in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Treatment of acute lymphoblastic leukemia in adults: results of the L-10 and L-10M protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Clinical importance of lymphoblasts with T markers in childhood acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Adult Acute Lymphoblastic Leukaemia: The Value of Therapy Intensification.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Selective Inhibition of Leukemia Cell Proliferation by BCR-ABL Antisense Oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Removal of tumour cells from bone marrow: an evaluation of the available techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2805%2980210-0

7 January 2021

10.1016/S0950-3536(05)80210-0

Identifiers

DOI

1 reference

21 September 2017

1 reference

PubMed ID

7803909